U.S. Markets closed
  • Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cubelast month

    Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Pressure BioSciences, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Pressure BioSciences, Inc. – Waters Corporation, Bruker Corporation, General Electric Company, Harvard Bioscience, Inc., Thermo Fisher Scientific Inc. and PerkinElmer, Inc. (WAT-US, BRKR-US, GE-US, HBIO-US, TMO-US and PKI-US) ... Read more (Read more...)

  • Zacks Small Cap Research4 months ago

    PBIO: Significant Revenue Growth Expected for 2017 and Beyond

    Total revenue for the first quarter 2017 was $0.55 million, as compared to total revenue of $0.51 million for the first quarter 2016, an increase of 8.0%. This increase was primarily attributable to an increase of 19% in the sale of instrument systems, from $332,016 in Q1 2016 to $396,095 in the same quarter of 2017. This decrease was primarily due to reduced R&D expenses combined with increased sales of product and services.

  • Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017
    Capital Cube4 months ago

    Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017

    Categories: Yahoo FinanceGet free summary analysis Pressure BioSciences, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Pressure BioSciences, Inc. – Waters Corporation, MOCON, Inc., PerkinElmer, Inc., General Electric Company, Harvard Bioscience, Inc., Thermo Fisher Scientific Inc. and Bruker Corporation (WAT-US, MOCO-US, PKI-US, GE-US, HBIO-US, ... Read more (Read more...)